T2 Biosystems, Inc. Cash and Cash Equivalents
T2 Biosystems, Inc. had Cash and Cash Equivalents of $2.08 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-11-14
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $2.08M.
- 2024-06-30: Cash and Cash Equivalents, at Carrying Value $4.25M.
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $6.21M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $15.69M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-09-30 | $2.08M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $4.25M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.21M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $15.69M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $24.32M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $16.08M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $10.12M 10-Q · filed 2024-05-06 |
| 2022-12-31 | $10.33M 10-K · filed 2024-04-01 |
| 2022-09-30 | $20.37M 10-Q · filed 2023-11-15 |
| 2022-06-30 | $13.21M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $9.40M 10-Q · filed 2023-05-22 |
| 2021-12-31 | $22.25M 10-K · filed 2023-03-31 |
| 2021-09-30 | $22.05M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $32.71M 10-Q · filed 2022-08-16 |
| 2021-03-31 | $10.69M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $16.79M 10-K · filed 2022-03-23 |
| 2020-09-30 | $19.06M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $26.55M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $36.32M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $11.03M 10-K · filed 2021-03-31 |
| 2019-09-30 | $16.21M 10-Q · filed 2019-11-18 |
| 2019-06-30 | $28.42M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $37.40M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $50.80M 10-K · filed 2020-03-16 |
| 2018-09-30 | $60.23M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $70.71M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $29.73M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $41.80M 10-K · filed 2020-03-16 |
| 2017-09-30 | $52.90M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $46.13M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $58.82M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $73.49M 10-K · filed 2018-03-19 |
| 2016-09-30 | $75.11M 10-Q · filed 2017-11-03 |
| 2016-06-30 | $50.22M 10-Q · filed 2017-08-04 |
| 2016-03-31 | $59.52M 10-Q · filed 2017-05-08 |
| 2015-12-31 | $73.66M 10-K · filed 2018-03-19 |
| 2015-09-30 | $40.12M 10-Q · filed 2016-11-08 |
| 2015-06-30 | $53.29M 10-Q · filed 2016-08-08 |
| 2015-03-31 | $65.30M 10-Q · filed 2016-05-09 |
| 2014-12-31 | $73.85M 10-K · filed 2018-03-19 |
| 2014-09-30 | $75.59M 10-Q · filed 2015-11-04 |
| 2014-06-30 | $15.88M 10-Q · filed 2015-08-05 |
| 2014-03-31 | $23.70M 10-Q · filed 2015-05-06 |
| 2013-12-31 | $30.20M 10-K · filed 2017-03-15 |
| 2013-09-30 | $35.22M 10-Q · filed 2014-11-05 |
| 2013-06-30 | $40.58M 10-Q · filed 2014-09-19 |
| 2012-12-31 | $9.71M 10-K · filed 2016-03-09 |
| 2011-12-31 | $18.74M 10-K · filed 2015-03-04 |